Semaglutide Week-by-Week
What to Expect (2026 Guide)
Week-by-week timeline of what to expect on Ozempic or Wegovy. Weight loss progression, side effects by week, and when results typically appear.
Your Semaglutide Journey
Note: Individual results vary significantly. These are typical experiences based on clinical trials and user reports.
FAQ
What Do Real Tracked Results Look Like?
Tracked reality is more modest — and far more varied — than headline trial numbers. Shotlee users with enough logged weigh-ins to measure show a median loss of 3.7% of body weight after 30 days of tracking (314 users) and 5.3% after 90 days (171 users). 84% are below their starting weight after the first month, easing to 75% by day 90 — and the spread is enormous: at 90 days, the top quarter of users are down 10.5% or more while the bottom quarter sit at 0.3% or less. Clinical trials report bigger averages, but those run a year-plus at full maintenance dose, while the first 90 days are mostly titration. Your own logged trend line — not a trial average — is the number that tells you whether your protocol is working. (Aggregated, anonymized Shotlee data as of July 2026.)
Guide FAQs
Week-by-week timeline of what to expect on Ozempic or Wegovy. Weight loss progression, side effects by week, and when results typically appear.
Yes. Shotlee supports tracking Semaglutide Week By Week doses, side effects, and health metrics. It is free to use.
Track Your Semaglutide Week By Week Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Semaglutide Week By Week

Semaglutide Greenlit for MASH Liver Disease Treatment
The MHRA has granted conditional approval for semaglutide to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
7 min read
Anandita Sundar's 7-Year Weight Loss Journey and Body Shaming
Anandita Sundar opens up about her seven-year weight loss journey, highlighting the profound impact of body shaming on mental health and her commitment to prioritizing well-being over societal expectations.
7 min read
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read